Promoting Repeat Blood Donation Through Social Media Among First-time Donors in a Peruvian Blood Bank

March 9, 2020 updated by: Joel Gustavo Rondón Rodríguez, Universidad Peruana Cayetano Heredia

Social Media-based Intervention to Promote Repeat Blood Donation Among First-time Blood Donors in a Peruvian Blood Bank: Randomized Controlled Trial

Blood donations are an important need worldwide. In Peru, only 10% of donations are voluntary, of which only a quarter are repeat donors. Repeat donations are crucial to maintaining a safe and adequate blood supply.

Social media presents a unique opportunity to promote blood donation, because of its increasing use and its prior successes in promoting positive health-related behaviors .

The present study aims to develop and evaluate a social media intervention - Facebook and WhatsApp - to improve communication and promote repeat blood donations in voluntary first-time donors attending donation campaigns organized by the Hospital Nacional Cayetano Heredia (HCH).

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Main Objective:

To evaluate the effect of social media in the promotion of repeat blood donation among first-time blood donors in a Peruvian blood bank.

Study design:

A randomized control trial will be conducted over a 6-month period, and will compare the rate of repeat blood donation who amongst first-time donors who received promotional messages through social media and those who did not.

Population:

Voluntary first-time blood donors who attend blood donation campaigns organized by the blood bank of the Hospital Nacional Cayetano Heredia (HCH), Lima - Peru.

Sample:

A sample of 105 participants per group was calculated, with a significance of 95% and a power of 80%, to show a difference of 20% in recurrence rate of blood donation between the two groups.

Group assignment:

Participant selection will occur at blood donation campaigns organized by the HCH blood bank. If inclusion and exclusion criteria are met, donors will be invited to participate in the study. After accepting and signing the informed consent form, donors will be randomly assigned to one of two groups using complete block randomization until a total of 212 participants are recruited: 106 in the intervention group and 106 in the control group. All participants will receive an introductory message through social media confirming their participation in the study.

Ethical considerations:

Written informed consent will be requested from participants. Data confidentiality will be maintained. Personal identifiers will be stored in a separate database, which will be password protected and accessible only to the research team.

Study Type

Interventional

Enrollment (Actual)

160

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Peru
    • Lima
      • San Martín De Porres, Lima, Peru, 15102
        • Hospital Nacional Cayetano Heredia Blood Bank

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Voluntary first-time Blood Donor
  • Eligible to donate blood again
  • Facebook or WhatsApp user

Exclusion Criteria:

  • Denial to participate in the study
  • Refusal to be contacted by social media

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
Participants will receive messages regarding blood donation promotion and campaigns through social media once or twice a week for six months.
Other: Social Media Publications
Messages will be elaborated prior to participant enrollment. Messages will be evaluated by three experts.
Sham Comparator: Control
Participants will receive a message regarding blood donation at the beginning of the study through social media. After four months they will receive another message including information about upcoming blood donation campaigns.
Other: Social Media Publications
Messages will be elaborated prior to participant enrollment. Messages will be evaluated by three experts.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Repeat Blood donation rate
Time Frame: 6 months
Rate of repeat blood donation will be assessed in both groups after intervention.
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time interval between blood donations
Time Frame: 6 months
Time interval between blood donations will be evaluated in both groups.
6 months
Readiness to Change
Time Frame: 6 months
Apply Transtheoretical Model of Change to assess first-time donors´ readiness to change.
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Universidad Peruana Cayetano Heredia

Investigators

  • Principal Investigator: Joel G Rondon Rodriguez, MD, Universidad Peruana Cayetano Heredia

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 20, 2019

Primary Completion (Actual)

January 25, 2020

Study Completion (Actual)

February 24, 2020

Study Registration Dates

First Submitted

June 13, 2019

First Submitted That Met QC Criteria

June 13, 2019

First Posted (Actual)

June 17, 2019

Study Record Updates

Last Update Posted (Actual)

March 11, 2020

Last Update Submitted That Met QC Criteria

March 9, 2020

Last Verified

March 1, 2020

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 103806

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Blood Donors

Clinical Trials on Social Media Publications

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Dominican Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe